Cargando…

1191. Pediatric Long Haul Post COVID-19: Is New Jersey’s Experience Different?

BACKGROUND: COVID-19 impacted nearly 4 million children, accounting for 14% of total cases in the US, 1.3-3.2% of total reported hospitalizations and less than 1% deaths attributed to COVID-19. Many studies report persistent symptoms in adults several months after acute COVID-19. Similar findings ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhargava, Aakriti, Farrand, Lauren, Zieniewicz, Stephen, Brenner, Dennis J, Yeh, Timothy S, Hasan, Uzma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644555/
http://dx.doi.org/10.1093/ofid/ofab466.1383
_version_ 1784610113238073344
author Bhargava, Aakriti
Farrand, Lauren
Zieniewicz, Stephen
Brenner, Dennis J
Yeh, Timothy S
Hasan, Uzma
author_facet Bhargava, Aakriti
Farrand, Lauren
Zieniewicz, Stephen
Brenner, Dennis J
Yeh, Timothy S
Hasan, Uzma
author_sort Bhargava, Aakriti
collection PubMed
description BACKGROUND: COVID-19 impacted nearly 4 million children, accounting for 14% of total cases in the US, 1.3-3.2% of total reported hospitalizations and less than 1% deaths attributed to COVID-19. Many studies report persistent symptoms in adults several months after acute COVID-19. Similar findings have been reported from a small cohort of children in Italy. To date there are no studies reviewing long haul symptoms in children in the US. METHODS: With the goal of defining long haul in pediatric population, and providing comprehensive care to these patients, RWJBarnabasHealth launched a post-COVID CARE program in October 2020 for children. The program has provided care for approximately 16 patients with COVID related Multisystem Inflammatory Syndrome (MIS-C) and 48 pediatric patients with COVID. The goal of the Pediatric Post-COVID CARE program was to provide a multidisciplinary approach for children ages 0-21 years impacted with COVID-19. This included patients who experienced ongoing symptoms >4 weeks from initial COVID-19 illness. All children were assessed by a pediatric infectious disease physician and triaged to appropriate subspecialties, all part of the long-haul care team. In addition, physical therapy and psychology support services were provided to facilitate return to normalcy. RESULTS: To date, our program has evaluated 64 patients. 28% experienced at least 1 symptom 4 weeks after acute COVID-19. Median age was 14 years and 77.8% were female. The follow-up study was conducted from October 2020 to May 2021. Data was collected 2 weeks, 6 weeks, 3 months, and 6 months post discharge or initial evaluation in clinic. 28% of patients were antibody positive, 55.6% experienced fatigue, 50% experienced shortness of breath or cough, 50% experienced ‘brain fog’,33% chest pain and 44.4% experienced anxiety and/or depression. CONCLUSION: Early identification of patients and comprehensive protocols may facilitate return to normalcy for children with lingering somatic symptoms worsened by impact of social isolation, economic stresses, lost parental jobs, and food insecurity among many other contributing factors. Further research is needed to determine why children of certain ethnicities are impacted differently. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-8644555
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86445552021-12-06 1191. Pediatric Long Haul Post COVID-19: Is New Jersey’s Experience Different? Bhargava, Aakriti Farrand, Lauren Zieniewicz, Stephen Brenner, Dennis J Yeh, Timothy S Hasan, Uzma Open Forum Infect Dis Poster Abstracts BACKGROUND: COVID-19 impacted nearly 4 million children, accounting for 14% of total cases in the US, 1.3-3.2% of total reported hospitalizations and less than 1% deaths attributed to COVID-19. Many studies report persistent symptoms in adults several months after acute COVID-19. Similar findings have been reported from a small cohort of children in Italy. To date there are no studies reviewing long haul symptoms in children in the US. METHODS: With the goal of defining long haul in pediatric population, and providing comprehensive care to these patients, RWJBarnabasHealth launched a post-COVID CARE program in October 2020 for children. The program has provided care for approximately 16 patients with COVID related Multisystem Inflammatory Syndrome (MIS-C) and 48 pediatric patients with COVID. The goal of the Pediatric Post-COVID CARE program was to provide a multidisciplinary approach for children ages 0-21 years impacted with COVID-19. This included patients who experienced ongoing symptoms >4 weeks from initial COVID-19 illness. All children were assessed by a pediatric infectious disease physician and triaged to appropriate subspecialties, all part of the long-haul care team. In addition, physical therapy and psychology support services were provided to facilitate return to normalcy. RESULTS: To date, our program has evaluated 64 patients. 28% experienced at least 1 symptom 4 weeks after acute COVID-19. Median age was 14 years and 77.8% were female. The follow-up study was conducted from October 2020 to May 2021. Data was collected 2 weeks, 6 weeks, 3 months, and 6 months post discharge or initial evaluation in clinic. 28% of patients were antibody positive, 55.6% experienced fatigue, 50% experienced shortness of breath or cough, 50% experienced ‘brain fog’,33% chest pain and 44.4% experienced anxiety and/or depression. CONCLUSION: Early identification of patients and comprehensive protocols may facilitate return to normalcy for children with lingering somatic symptoms worsened by impact of social isolation, economic stresses, lost parental jobs, and food insecurity among many other contributing factors. Further research is needed to determine why children of certain ethnicities are impacted differently. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8644555/ http://dx.doi.org/10.1093/ofid/ofab466.1383 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Bhargava, Aakriti
Farrand, Lauren
Zieniewicz, Stephen
Brenner, Dennis J
Yeh, Timothy S
Hasan, Uzma
1191. Pediatric Long Haul Post COVID-19: Is New Jersey’s Experience Different?
title 1191. Pediatric Long Haul Post COVID-19: Is New Jersey’s Experience Different?
title_full 1191. Pediatric Long Haul Post COVID-19: Is New Jersey’s Experience Different?
title_fullStr 1191. Pediatric Long Haul Post COVID-19: Is New Jersey’s Experience Different?
title_full_unstemmed 1191. Pediatric Long Haul Post COVID-19: Is New Jersey’s Experience Different?
title_short 1191. Pediatric Long Haul Post COVID-19: Is New Jersey’s Experience Different?
title_sort 1191. pediatric long haul post covid-19: is new jersey’s experience different?
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644555/
http://dx.doi.org/10.1093/ofid/ofab466.1383
work_keys_str_mv AT bhargavaaakriti 1191pediatriclonghaulpostcovid19isnewjerseysexperiencedifferent
AT farrandlauren 1191pediatriclonghaulpostcovid19isnewjerseysexperiencedifferent
AT zieniewiczstephen 1191pediatriclonghaulpostcovid19isnewjerseysexperiencedifferent
AT brennerdennisj 1191pediatriclonghaulpostcovid19isnewjerseysexperiencedifferent
AT yehtimothys 1191pediatriclonghaulpostcovid19isnewjerseysexperiencedifferent
AT hasanuzma 1191pediatriclonghaulpostcovid19isnewjerseysexperiencedifferent